Dr Ian Ellul PhD[Paed.][Melit.] has been the managing editor of The Synapse Journal since 2005. He was also Director of Pharmacy Services at a private hospital group, the government's Clinical Trials Coordinator for trials conducted in Malta, as well as senior regulatory affairs officer.
By Ian Ellul - The application of AI in medicine has always intrigued clinicians, so much so that Elsevier started publishing the journal Artificial Intelligence in Medicine way back in 1989.
by Dr Ian Ellul - On 29 March 2017, the European Council received the notification by the UK of its intention to withdraw from the EU.
by Ian Ellul - Last May, Health Secretary Jeremy Hunt announced that 450,000 women between the ages of 68 and 71 in the UK failed to receive invitations for a final routine breast cancer screening.
Ian Ellul - As discussed in the last editorial, modern gene editing is quite precise but it is not perfect.
I wish to start 2018 by discussing gene editing which, following last year’s remarkable advances, is rumoured to continue to make a star appearance on stage. Gene editing basically rewrites DNA, disabling target genes, correcting harmful mutations and changing the activity of specific genes.